XASXEPN
Market cap4mUSD
Dec 18, Last price
0.02AUD
Name
Epsilon Healthcare Ltd
Chart & Performance
Profile
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑09 | |
Income | |||||||
Revenues | 7,112 29.36% | 5,498 -25.29% | |||||
Cost of revenue | 10,406 | 10,886 | |||||
Unusual Expense (Income) | |||||||
NOPBT | (3,294) | (5,388) | |||||
NOPBT Margin | |||||||
Operating Taxes | 822 | (1,457) | |||||
Tax Rate | |||||||
NOPAT | (4,116) | (3,930) | |||||
Net income | (12,677) 42.31% | (8,908) -18.63% | |||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 5,778 | 2,514 | |||||
BB yield | -76.95% | -18.34% | |||||
Debt | |||||||
Debt current | 2,539 | 3,666 | |||||
Long-term debt | 1,309 | 1,435 | |||||
Deferred revenue | |||||||
Other long-term liabilities | (11) | 593 | |||||
Net debt | 2,987 | 2,639 | |||||
Cash flow | |||||||
Cash from operating activities | (2,571) | (5,429) | |||||
CAPEX | (529) | (748) | |||||
Cash from investing activities | (529) | (738) | |||||
Cash from financing activities | 1,607 | 1,472 | |||||
FCF | (262) | (2,575) | |||||
Balance | |||||||
Cash | 862 | 2,336 | |||||
Long term investments | 127 | ||||||
Excess cash | 506 | 2,188 | |||||
Stockholders' equity | 9,881 | 20,320 | |||||
Invested Capital | 11,952 | 22,303 | |||||
ROIC | |||||||
ROCE | |||||||
EV | |||||||
Common stock shares outstanding | 300,354 | 193,043 | |||||
Price | 0.03 -64.79% | 0.07 -69.79% | |||||
Market cap | 7,509 -45.22% | 13,706 -63.30% | |||||
EV | 10,496 | 16,345 | |||||
EBITDA | (1,439) | (4,245) | |||||
EV/EBITDA | |||||||
Interest | 578 | 799 | |||||
Interest/NOPBT |